Selective serotonin reuptake inhibitors (SSRIs) can’t be recommended for treating autism in children or adults at this point, according to a Cochrane review. The antidepressants have shown emerging evidence of harm without any benefit in pediatric cases, reported Katrina Williams, PhD, of the University of New South Wales and Sydney Children’s Hospital in Sydney, Australia, and colleagues in the Cochrane Library.
